Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Financial Ratios

CORONA REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Financial Ratios History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Operational & Financial Ratios
   Earnings Per Share (Rs) 30.2724.4314.8013.89
   CEPS(Rs) 36.4630.5119.4217.17
   DPS(Rs) 10.007.313.702.77
   Book NAV/Share(Rs) 122.1299.1478.5566.80
   Tax Rate(%) 23.0024.7323.6123.41
Margin Ratios
   Core EBITDA Margin(%) 21.2720.4214.9214.25
   EBIT Margin(%) 17.9317.8012.8212.82
   Pre Tax Margin(%) 17.4316.8911.4212.35
   PAT Margin (%) 13.4212.728.739.46
   Cash Profit Margin (%) 16.1715.8811.4511.69
Performance Ratios
   ROA(%) 15.9915.7911.7712.82
   ROE(%) 27.3627.5020.3620.79
   ROCE(%) 31.7432.5925.9328.03
   Asset Turnover(x) 1.191.241.351.36
   Sales/Fixed Asset(x) 2.252.382.813.50
   Working Capital/Sales(x) -107.2611.8415.785.83
Efficiency Ratios
   Fixed Capital/Sales(x) 0.440.420.360.29
   Receivable days 34.9133.8932.8935.35
   Inventory Days 33.6735.3835.8542.83
   Payable days 203.24198.93167.89163.28
Valuation Parameters
   PER(x) 51.41---
   PCE(x) 42.68---
   Price/Book(x) 12.74---
   Yield(%) 0.64---
   EV/Net Sales(x) 6.850.050.12-0.01
   EV/Core EBITDA(x) 31.620.220.78-0.10
   EV/EBIT(x) 38.870.260.94-0.11
   EV/CE(x) 10.810.080.20-0.03
   M Cap / Sales 6.78---
Growth Ratio
   Net Sales Growth(%) 17.2817.9414.75-
   Core EBITDA Growth(%) 23.6652.5619.37-
   EBIT Growth(%) 18.2957.3415.43-
   PAT Growth(%) 23.8865.116.56-
   EPS Growth(%) 23.8865.116.56-
Financial Stability Ratios
   Total Debt/Equity(x) 0.190.100.280.01
   Current Ratio(x) 0.971.301.241.74
   Quick Ratio(x) 0.700.910.881.23
   Interest Cover(x) 35.4919.739.2126.98
   Total Debt/Mcap(x) 0.02---

Compare Financial Ratios of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,259.3 Cr 2% 17.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,005.0 Cr 2.7% 7.5% 12.8% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4.2% 3.9% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹163,246.0 Cr 4.3% 11.2% 42.5% Stock Analytics
CIPLA ₹118,854.0 Cr 0.4% 5.3% -3% Stock Analytics
DR REDDYS LABORATORIES ₹114,246.0 Cr 0.9% 8% 5.6% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

2%

17.7%

NA
SENSEX

2%

5.3%

-6.5%


You may also like the below Video Courses